Longeveron, Inc. (LGVN)
6.77
-0.03
(-0.44%)
USD |
NASDAQ |
Aug 28, 14:36
Longeveron Market Cap : 214.73M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 215.69M |
| August 26, 2026 | 223.08M |
| August 25, 2026 | 215.69M |
| August 24, 2026 | 265.74M |
| August 21, 2026 | 267.99M |
| August 20, 2026 | 262.69M |
| August 19, 2026 | 260.82M |
| August 18, 2026 | 249.69M |
| August 17, 2026 | 260.09M |
| August 14, 2026 | 234.69M |
| August 13, 2026 | 221.27M |
| August 12, 2026 | 236.91M |
| August 11, 2026 | 219.52M |
| August 10, 2026 | 233.54M |
| August 07, 2026 | 242.96M |
| August 06, 2026 | 245.34M |
| August 05, 2026 | 230.63M |
| August 04, 2026 | 235.38M |
| August 03, 2026 | 232.18M |
| July 31, 2026 | 222.51M |
| July 30, 2026 | 214.20M |
| July 29, 2026 | 188.73M |
| July 28, 2026 | 190.72M |
| July 27, 2026 | 193.74M |
| July 24, 2026 | 190.31M |
| Date | Value |
|---|---|
| July 23, 2026 | 192.60M |
| July 22, 2026 | 198.72M |
| July 21, 2026 | 193.99M |
| July 20, 2026 | 191.01M |
| July 17, 2026 | 197.29M |
| July 16, 2026 | 194.56M |
| July 15, 2026 | 201.51M |
| July 14, 2026 | 197.38M |
| July 13, 2026 | 200.14M |
| July 10, 2026 | 214.10M |
| July 09, 2026 | 206.33M |
| July 08, 2026 | 203.95M |
| July 07, 2026 | 200.52M |
| July 06, 2026 | 206.01M |
| July 02, 2026 | 219.02M |
| July 01, 2026 | 231.26M |
| June 30, 2026 | 222.98M |
| June 29, 2026 | 218.51M |
| June 26, 2026 | 220.23M |
| June 25, 2026 | 224.39M |
| June 24, 2026 | 227.78M |
| June 23, 2026 | 246.24M |
| June 22, 2026 | 246.37M |
| June 18, 2026 | 252.43M |
| June 17, 2026 | 258.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.99B |
| Oncolytics Biotech, Inc. | 102.75M |
| Sangamo Therapeutics, Inc. | 63.55M |
| Sarepta Therapeutics, Inc. | 2.233B |
| Anixa Biosciences, Inc. | 119.75M |
Market Cap Related Metrics
| PS Ratio | 13.90 |
| Price to Book Value | 2.064 |
| Price | 6.77 |
| Earnings Yield | -149.9% |